Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases

被引:106
|
作者
Dutko, JA
Schäfer, A
Kenny, AE
Cullen, BR
Curcio, MJ
机构
[1] SUNY Albany, Wadsworth Ctr, Lab Dev Genet, Albany, NY 12201 USA
[2] SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA
[3] Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA
关键词
D O I
10.1016/j.cub.2005.02.051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian APOBEC3 family of cytidine deaminases includes several members that possess potent antiretroviral activity. Human APOBEC3F and APOBEC3G are specifically incorporated into human immunodeficiency virus type 1 (HIV-1) progeny virions in the absence of virion infectivity factor (Vif), where they deaminate deoxycytidine to deoxyuridine on the minus strand of nascent reverse transcripts. Editing of the HIV-1 cDNA leads to its degradation or to G to A hypermutation of the integrated provirus [1-8]. Here, we show that APOBEC3 proteins also restrict the activity of a distantly related long terminal repeat (LTR) retrotransposon. When expressed in the yeast Saccharomyces cerevisiae, human APOBEC3C, APOBEC3F, or APOBEC3G or mouse APOBEC3 potently inhibit replication of the Ty1 LTR retrotransposon. APOBEC3G interacts with Ty1 Gag and is packaged into Ty1 virus-like particles (VLPs) by a mechanism that closely resembles the one it uses to enter HIV-1 virions. Expression of APOBEC3G results in a reduced level of Ty1 cDNA integration and G to A editing of integrated Ty1 cDNA. Our findings indicate that APOBEC3G restricts Ty1 and HIV-1 by similar mechanisms and suggest that the APOBEC3 proteins target a substantially broader spectrum of retroelements than previously appreciated.
引用
收藏
页码:661 / 666
页数:6
相关论文
共 50 条
  • [31] Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains
    Hakata, Yoshiyuki
    Landau, Nathaniel R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (48) : 36624 - 36631
  • [32] Genetic Editing of Herpes Simplex Virus 1 and Epstein-Barr Herpesvirus Genomes by Human APOBEC3 Cytidine Deaminases in Culture and In Vivo
    Suspene, Rodolphe
    Aynaud, Marie-Ming
    Koch, Stefanie
    Pasdeloup, David
    Labetoulle, Marc
    Gaertner, Barbara
    Vartanian, Jean-Pierre
    Meyerhans, Andreas
    Wain-Hobson, Simon
    JOURNAL OF VIROLOGY, 2011, 85 (15) : 7594 - 7602
  • [33] Development of small molecule inhibitors of APOBEC3 DNA cytosine deaminases
    Harki, Daniel A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [34] Elucidating the role and function of APOBEC3 DNA deaminases in myeloproliferative neoplasms
    Isquith, Jane
    Jiang, Qingfei
    Diep, Raymond
    Pham, Jessica
    Holm, Frida
    Jamieson, Catriona
    CANCER RESEARCH, 2019, 79 (13)
  • [35] The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases
    Scholtes, Gael K.
    Sawyer, Aubrey M.
    Vaca, Cristina C.
    Clerc, Isabelle
    Roh, Meejeon
    Song, Chisu
    D'Aquila, Richard T.
    TRANSLATIONAL RESEARCH, 2021, 237 : 1 - 15
  • [36] HIV-1 Vif versus the APOBEC3 cytidine deaminases: An intracellular duel between pathogen and host restriction factors
    Wissing, Silke
    Galloway, Nicole L. K.
    Greene, Warner C.
    MOLECULAR ASPECTS OF MEDICINE, 2010, 31 (05) : 383 - 397
  • [37] Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases
    Zhang, Wenyan
    Huang, Michael
    Wang, Tao
    Tan, Lindi
    Tian, Chunjuan
    Yu, Xianghui
    Kong, Wei
    Yu, Xiao-Fang
    CELLULAR MICROBIOLOGY, 2008, 10 (08) : 1662 - 1675
  • [39] Hepatitis B: modern concepts in pathogenesis - APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus
    Bonvin, Marianne
    Greeve, Jobst
    CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (03) : 298 - 303
  • [40] APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
    Bogerd, HP
    Wiegand, HL
    Doehle, BP
    Lueders, KK
    Cullen, BR
    NUCLEIC ACIDS RESEARCH, 2006, 34 (01) : 89 - 95